-
CBD For Traumatic Brain Injuries? Oral Administration Reduces Levels Of Neuronal Death In Animal Model, New Study
Monday, February 6, 2023 - 11:04am | 589HempMeds, a subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA) took part in a collaboration on a study to demonstrate the effectiveness of hemp-based CBD in the treatment of Parkinson's Disease. The company is also collaborating with the Center for Research and Advanced Studies of Neurological...
-
Medical Marijuana Q3 Revenue Declines 37% Sequentially, Here Are The Details
Tuesday, November 22, 2022 - 11:02am | 389Medical Marijuana, Inc. (OTCPK:MJNA) released its financial results for the quarter ending September 30, 2022, revealing net revenue of $4.9 million, an unfavorable decrease of 37% compared to $7.8 million in the previous quarter. Q3 2022 Financial and Operational Highlights Gross profit was $4...
-
Medical Marijuana Signs Distribution Agreement With Complete Hemp Technologies
Thursday, September 8, 2022 - 10:26am | 429Kannaway, a subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA), has signed a distribution agreement with long-time partner Complete Hemp Technologies (CHT) to expand its capabilities in the European market. The agreement adds warehousing and daily operations to the services that CHT already...
-
Medical Marijuana Q2 Revenue Declines 18.75% YoY, Here Are The Details
Thursday, August 18, 2022 - 10:42am | 416Medical Marijuana, Inc. (OTCPK:MJNA) released financial results for the quarter ending June 30, revealing net revenue of $7.8 million, a decrease of 18.75% compared to 9.6 million in Q2 2021. Q2 2022 Financial and Operational Highlights Gross profit for the period ending June 30, 2022, was $6...
-
EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy
Wednesday, July 6, 2022 - 8:30am | 438Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is collaborating with Hospital del Cruce to conduct a study in Argentina on the efficiency of...
-
Medical Marijuana Subsidiary Kannaway Reports Largest Revenue In Company History For South Africa Division
Thursday, April 14, 2022 - 2:29pm | 242Kannaway subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA) achieved its largest revenue month in the company’s history in its South Africa division for March 2022. Africa’s cannabis industry is rapidly expanding, becoming one of the company’s top international growth markets....
-
Medical Marijuana Subsidiary Kannaway's CBD Products Close To Validation By UK Food Standard Agency
Monday, April 4, 2022 - 3:24pm | 388Kannaway, subsidiary of Medical Marijuana, Inc., (OTCPK:MJNA) has been included on the recently published list of brands that have submitted novel foods applications to the UK Food Standard Agencies for their CBD products. This new list contains the names of products that were on the market before...
-
Medical Marijuana Eliminates $10M Of Debt From Its Balance Sheet
Thursday, March 10, 2022 - 11:37am | 296Medical Marijuana, Inc. (OTC: MJNA) has satisfied and retired two of its three major outstanding debt liabilities, eliminating over $10 million of principal debt from its balance sheet. The satisfaction of the debt eliminates long-standing liabilities and aligns with the company's goal of...
-
Medical Marijuana's Kannaway To Launch Its First CBD Product With 1% THC At Its Event In Prague
Tuesday, March 1, 2022 - 11:46am | 243Medical Marijuana, Inc. (OTC: MJNA) confirmed Tuesday that its subsidiary Kannaway will host its Europe Regional Event in Prague on March 5 and 6, 2022. The event, which will take place at the Wellness Hotel Step, will allow Kannaway brand ambassadors to network with top Kannaway Europe leaders,...
-
Medical Marijuana's HempMeds Brasil Sponsors Brazilian Obesity Medicine Symposium
Thursday, February 24, 2022 - 12:44pm | 282HempMeds Brasil subsidiary of Medical Marijuana, Inc. (OTC: MJNA) is sponsoring the Brazilian Society of Obesity Medicine’s first Obesity Medicine Symposium on March 3-6. The symposium, which will take place at the Centro South Convention Center in Santa Catarina, is designed to unite...
-
Medical Marijuana Promotes Todd Morrow To President
Thursday, February 10, 2022 - 11:34am | 286Medical Marijuana, Inc. (OTC: MJNA) announced that the company’s CFO Todd Morrow, has been promoted and will now serve as the company’s president. Prior to joining the company, Morrow, who has more than two decades of experience in product development, merchandising and...
-
Medical Marijuana's Kannaway Expands In South Africa With New Office & Warehouse in Johannesburg
Tuesday, February 1, 2022 - 12:58pm | 268Medical Marijuana, Inc. (OTC: MJNA) announced that its subsidiary Kannaway has opened a new office and warehouse in South Africa. The 3,326 square foot combined facility is positioned just east of Johannesburg, making it convenient for employees and visitors to access. Why It Matters The...
-
Cannabis In Poland: Medical Marijuana, Inc.'s Kannaway Opens Office And Warehouse In Warsaw
Thursday, January 13, 2022 - 10:14am | 347Medical Marijuana, Inc. (OTC: MJNA), a publicly-traded cannabis company in the U.S., announced on Wednesday that its subsidiary Kannaway® has opened a new office and warehouse in Warsaw, Poland.The new 7,771 square foot warehouse is strategically positioned near the Warsaw airport and city...
-
Cannabis Movers & Shakers: MediPharm Labs, Kannaway, Affinor Growers, The Weldon Project
Wednesday, December 8, 2021 - 12:10pm | 1154MediPharm Labs Announces Board Shake-Up CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced changes to its board of directors Tuesday. The company, based in Barrie, Ontario, revealed that Pat McCutcheon, Warren Everitt and Keith...
-
Medical Marijuana Inc's Stock Down On Q3 Results And Slight Revenue Decline
Wednesday, November 17, 2021 - 12:56pm | 474Medical Marijuana, Inc. (OTC: MJNA) reported financial results Wednesday for the quarter ending September 30, 2021. Q3 2021 Financial Highlights Generated $9.2 million in net revenue, down from $9.6 million in net revenue in the second quarter. The net ordinary loss was $640 000. Gross profit...